[The use of tramadol-HCl (Tramal) as adjuvant in regional anaesthesia. Clinical report (author's transl)].
The report deals with the clinical use and effects of tramadol-HCl (Tramal) as an adjuvant in regional anaesthesia. As distinguished from triflupromazine, diazepam, flunitrazepam, droperidol, piritramide and pentazocine this drug can be applied safely, reliably and without secondary effects in patients of all ages for sedation and analgesia without loss of cooperation (no sleep, no pain from body-positioning, no psychic distress) and for the prevention of centralisation in the unblocked region (no trembling- and freezing-reaction, no alteration of the blood-gas-analysis.
D000765:Anesthesia, Conduction; D003511:Cyclohexanols; D003975:Diazepam; D004329:Droperidol; D005445:Flunitrazepam; D006801:Humans; D010423:Pentazocine; D010892:Pirinitramide; D014147:Tramadol / Q000009:adverse effects; D014273:Triflupromazine
D003511:Cyclohexanols; D014147:Tramadol; D010892:Pirinitramide; D005445:Flunitrazepam; D004329:Droperidol; D003975:Diazepam; D014273:Triflupromazine; D010423:Pentazocine
Anwendung von Tramadol-HCl (Tramal, Firma Grünenthal) als Adjuvans bei Regionalanaesthesie. Klinische Mitteilung.